Differences in BAL fluid variables in interstitial lung diseases evaluated by discriminant analysis

The aim of this study was to investigate the possibility of distinguishing between patients with similarities in clinical presentation, suffering from three frequently occurring interstitial lung diseases, by means of discriminant analysis, using a number of selected variables derived from bronchoalveolar lavage fluid (BALF) analysis. The study involved all 277 patients, who had an initial bronchoalveolar lavage (BAL) in the period 1980-1990. These patients belonged to the following diagnostic groups: sarcoidosis (n = 193), subacute extrinsic allergic alveolitis (EAA) (n = 39) and idiopathic pulmonary fibrosis (IPF) (n = 45). Thirty healthy volunteers were used as controls. Cellular and non-cellular constituents of BALF were evaluated. Variables, which could be used to discriminate among the three diagnostic groups were: yield of recovered BALF, total cell count, and percentages of alveolar macrophages, lymphocytes, polymorphonuclear neutrophils, eosinophils and plasma cells in BALF. When the set of data used to predict the membership of patients to diagnostic groups (test set) was the same as that in which the discriminant analysis was performed (learning set), 93% of the cases were correctly classified. This percentage decreased to 90%, however, when the test set was different from the learning set. It is possible to discriminate among patients with sarcoidosis, EAA or IPF with these selected variables. It appears that bronchoalveolar lavage (BAL) is useful as an adjunct in concert with other diagnostic methods.

This article has been cited by other articles:

				S. Greco, A. Marruchella, M. Massari, and C. Saltini Predictive value of BAL cellular analysis in differentiating pulmonary tuberculosis and sarcoidosis Eur. Respir. J., August 1, 2005; 26(2): 360 - 362. [Full Text] [PDF]

				L. Welker, R.A. Jorres, U. Costabel, and H. Magnussen Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases Eur. Respir. J., December 1, 2004; 24(6): 1000 - 1006. [Abstract] [Full Text] [PDF]

				R.M. du Bois and A.U. Wells Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Eur. Respir. J., July 1, 2001; 18(32_suppl): 43S - 55s. [Abstract] [Full Text] [PDF]

				A. XAUBET, C. AGUSTI, P. LUBURICH, J. ROCA, C. MONTON, M. C. AYUSO, J. A. BARBERA, and R. RODRIGUEZ-ROISIN Pulmonary Function Tests and CT Scan in the Management of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 431 - 436. [Abstract] [Full Text] [PDF]